UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib

Clinical pharmacology and therapeutics, 2010-02, Vol.87 (2), p.197-203

2010

Volltextzugriff (PDF)

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

Journal of clinical pharmacology, 2002-11, Vol.42 (11), p.1228-1236

2002

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

Journal of clinical pharmacology, 2003-02, Vol.43 (2), p.154-162

2003

Volltextzugriff (PDF)

Clinical pharmacokinetics of imatinib

Clinical pharmacokinetics, 2005-01, Vol.44 (9), p.879-894

2005

Volltextzugriff (PDF)

Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial

Cancer chemotherapy and pharmacology, 2012-05, Vol.69 (5), p.1145-1154

2012

Volltextzugriff (PDF)

Biodistribution and plasma protein binding of zoledronic acid

Drug metabolism and disposition, 2008-10, Vol.36 (10), p.2043-2049

2008

Volltextzugriff (PDF)

Lake Louise consensus conference on cyclosporin monitoring in organ transplantation : report of the consensus panel

Therapeutic drug monitoring, 1995-12, Vol.17 (6), p.642-654

1995

Volltextzugriff (PDF)

Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

Journal of clinical pharmacology, 2011-01, Vol.51 (1), p.75-83

2011

Volltextzugriff (PDF)

Metabolism of the new immunosuppressor cyclosporin G by human liver cytochromes P450

Biochemical pharmacology, 1996-03, Vol.51 (5), p.591-598

1996

Volltextzugriff (PDF)

The Pharmacokinetics and Bioavailability of Clemastine and Phenylpropanolamine in Single-Component and Combination Formulations

Journal of clinical pharmacology, 1996-10, Vol.36 (10), p.911-922

1996

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly

Clinical pharmacology and therapeutics, 2005-07, Vol.78 (1), p.69-80

2005

Volltextzugriff (PDF)

Regular dosing of zoledronic acid maintains continuous suppression of osteolysis in patients with malignant bone disease

Bone (New York, N.Y.), 2008-03, Vol.42, p.S107-S108

2008

Volltextzugriff (PDF)

Effect of nilotinib on the pharmacokinetics and pharmacodynamics of warfarin

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.7063-7063

2009

Volltextzugriff (PDF)

Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.7053-7053

2009

Volltextzugriff (PDF)

Pharmacokinetics and metabolism of cyclosporin G in humans

Drug metabolism and disposition, 1994-11, Vol.22 (6), p.873

1994

Volltextzugriff (PDF)

Increased circulating levels of bromocriptine after vaginal compared with oral administration

Fertility and sterility, 1991-05, Vol.55 (5), p.882-884

1991

Volltextzugriff (PDF)

Pharmacokinetics (PK) and pharmacodynamics (PD) of midostaurin (PKC412) in patients with acute myeloid leukemia (AML)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7064-7064

2008

Volltextzugriff (PDF)

Clinical pharmacokinetics (PK) of two oral dosing schedules of gimatecan in a phase I study: Implications for safety and efficacy

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2512-2512

2008

Volltextzugriff (PDF)

Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules

Cancer chemotherapy and pharmacology, 2004-05, Vol.53 (5), p.433-438

2004

Volltextzugriff (PDF)

Determination of cyclosporine concentrations with monoclonal antibodies

Clinical chemistry (Baltimore, Md.), 1987-12, Vol.33 (12), p.2225-2229

1987

Volltextzugriff (PDF)

Modelling TKI258 exposure and biomarker response in support of phase I dosing schedule finding

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14691-14691

2008

Volltextzugriff (PDF)

Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy

Obstetrics and gynecology (New York. 1953), 1989-03, Vol.73 (3 Pt 2), p.517

1989

Volltextzugriff (PDF)

Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine

Journal of pharmaceutical and biomedical analysis, 2002-11, Vol.30 (4), p.897-911

2002

Volltextzugriff (PDF)

Renal safety evaluation of zoledronic acid and thalidomide when used as post-stem cell transplant maintenance therapy in multiple myeloma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6655-6655

2004

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(37)
Life Sciences & Biomedicine
(36)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Male
(29)
Pharmacology. Drug Treatments
(28)
Pharmacology & Pharmacy
(27)
Adult
(25)
Female
(23)
Middle Aged
(17)
Radioimmunoassay
(12)
Aged
(9)
Physical Sciences
(8)
Biological Availability
(7)
Dose-Response Relationship, Drug
(7)
Immunomodulators
(7)
Kinetics
(7)
Animals
(6)
Antineoplastic Agents - Pharmacokinetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

Clinical pharmacokinetics of imatinib

Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial

Biodistribution and plasma protein binding of zoledronic acid

Lake Louise consensus conference on cyclosporin monitoring in organ transplantation : report of the consensus panel

Effects of Rifampin and Ketoconazole on the Pharmacokinetics of Nilotinib in Healthy Participants

Metabolism of the new immunosuppressor cyclosporin G by human liver cytochromes P450

The Pharmacokinetics and Bioavailability of Clemastine and Phenylpropanolamine in Single-Component and Combination Formulations

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly

Regular dosing of zoledronic acid maintains continuous suppression of osteolysis in patients with malignant bone disease

Effect of nilotinib on the pharmacokinetics and pharmacodynamics of warfarin

Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib

Pharmacokinetics and metabolism of cyclosporin G in humans

Increased circulating levels of bromocriptine after vaginal compared with oral administration

Pharmacokinetics (PK) and pharmacodynamics (PD) of midostaurin (PKC412) in patients with acute myeloid leukemia (AML)

Clinical pharmacokinetics (PK) of two oral dosing schedules of gimatecan in a phase I study: Implications for safety and efficacy

Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules

Determination of cyclosporine concentrations with monoclonal antibodies

Modelling TKI258 exposure and biomarker response in support of phase I dosing schedule finding

Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy

Development and validation of a highly sensitive RIA for zoledronic acid, a new potent heterocyclic bisphosphonate, in human serum, plasma and urine

Renal safety evaluation of zoledronic acid and thalidomide when used as post-stem cell transplant maintenance therapy in multiple myeloma

Suchergebnisse filtern